πŸ‡ΊπŸ‡Έ FDA
Patent

US 12297447

Gene therapy for juvenile Batten disease

granted A61KA61K48/00A61P

Quick answer

US patent 12297447 (Gene therapy for juvenile Batten disease) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K48/00, A61P, A61P25/00